Dextrorphan: an antagonist for phencyclidine receptors.

Area of Science:

• Pharmacology
• Neuroscience
• Receptor Binding Assays

Background:

• Phencyclidine (PCP) is a dissociative anesthetic with complex neurochemical effects.
• Understanding interactions at the PCP receptor is crucial for developing novel therapeutics.
• Dextrorphan's precise role as a modulator of PCP activity requires detailed investigation.

Purpose of the Study:

• To investigate the antagonistic effects of dextrorphan on phencyclidine (PCP) actions.
• To characterize dextrorphan's binding affinity and bioactivity at PCP receptors.
• To elucidate the mechanism by which dextrorphan modulates PCP-induced norepinephrine release.

Main Methods:

• Radio-binding assays were employed to determine dextrorphan's affinity for PCP receptors.
• Bioassays using rabbit ear artery preparations assessed dextrorphan's functional antagonism of PCP.
• High-Performance Liquid Chromatography (HPLC) detected changes in norepinephrine content.

Main Results:

• Dextrorphan exhibited high affinity for PCP receptors in rabbit mesenteric blood vessels.
• In vitro studies demonstrated dextrorphan's dose-dependent antagonism of PCP's effects, shifting the dose-response curve rightward.
• Dextrorphan reversed PCP-induced increases in norepinephrine levels in vascular preparations.

Conclusions:

• Dextrorphan functions as a competitive antagonist at PCP receptors.
• The compound possesses minimal PCP-like agonistic activity.
• Dextrorphan effectively counteracts PCP's influence on norepinephrine release, suggesting therapeutic potential.